New developments in alpha 1-antitrypsin deficiency

被引:7
|
作者
Aboussouan, LS
Stoller, JK
机构
[1] Wayne State Univ, Sch Med, Div Pulm & Crit Care Med, Harper Hosp, Detroit, MI 48201 USA
[2] Cleveland Clin Fdn, Dept Pulm & Crit Care Med, Cleveland, OH 44195 USA
关键词
alpha 1-antitrypsin deficiency; augmentation therapy; loop-sheet polymerization; lung physiopathology; lung transplantation; lung volume reduction;
D O I
10.1055/s-2007-1021327
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Alpha 1-antitrypsin deficiency is an autosomal codominant condition associated with the development of premature emphysema, chronic liver disease, diseases of arterial vascular tissue such as aneurysm formation, and possibly vasculitis. Whereas unchecked proteolytic activity of neutrophil elastase is the likely etiology of premature emphysema and diseases of arterial vascular tissue, chronic liver disease has only recently been proposed to be due to loop-sheet polymerization of the most common deficiency variant of the alpha 1-antitrypsin molecule, the PI*ZZ mutant. Recent evidence suggests that this disorder is underrecognized by health care providers with only 4% of the estimated 60,000 to 100,000 Americans having been identified. Intravenous augmentation therapy with purified pooled plasma derived alpha 1-antitrypsin has been shown to have biochemical efficacy in raising serum and alveolar lining fluid levels to above protective thresholds. Although uncontrolled studies suggest additional clinical efficacy, no randomized clinical trials of intravenous augmentation therapy have been reported to date. The use of gene therapy is currently limited by difficulties in obtaining sustained and therapeutic levels of alpha 1-antitrypsin expression. Alpha 1-antitrypsin deficiency accounts for 11% of all lung transplants performed, with post-transplantation survival rates of 45% at 5 years matching those of lung transplantation for chronic obstructive pulmonary disease in general. These recent advances raise further challenges such as the role of population screening, the prospects of newer therapies such as inhaled augmentation and gene therapy, and the feasibility of randomized placebo-controlled clinical trials.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 50 条
  • [31] Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
    Lee, P
    Gildea, TR
    Stoller, JK
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2002, 69 (12) : 928 - +
  • [32] Panniculitis in α1-Antitrypsin Deficiency
    Xu, Kathryn K.
    Proffer, Sydney L.
    Wieland, Carilyn
    MAYO CLINIC PROCEEDINGS, 2024, 99 (08) : 1210 - 1211
  • [33] LIQUEFYING PANNICULITIS - CUTANEOUS SYMPTOMS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
    GROSSHAN.E
    WARTER, J
    STORCK, D
    BASSET, A
    BULLETIN DE LA SOCIETE FRANCAISE DE DERMATOLOGIE ET DE SYPHILIGRAPHIE, 1973, 80 (03): : 244 - 247
  • [34] Alpha 1-antitrypsin deficiency and the risk for Wegener's granulomatosis
    Mahr, Alfred
    Edberg, Jeffrey
    Stone, John
    Hoffman, Gary
    St Clair, E. William
    Specks, Ulrich
    Dellaripa, Paul
    Spiera, Robert
    Rouhani, Farshid
    Brantly, Mark
    Merkel, Peter
    APMIS, 2009, 117 : 157 - 157
  • [36] Cirrhosis in children and SZ phenotype alpha 1-antitrypsin deficiency
    Budin, C
    Rivet, C
    Dumortier, J
    Legall, C
    Bouvier, R
    Lachaux, A
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (02): : 206 - 207
  • [37] α1-antitrypsin deficiency and inflammation
    Ekeowa, Ugo I.
    Marciniak, Stefan J.
    Lomas, David A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (02) : 243 - 252
  • [38] Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia
    Ray, Debidas
    Harikrishna, S.
    Immanuel, Chandra
    Victor, Lalitha
    Subramanyam, Sudha
    Kumaraswami, V.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 134 (01) : 79 - 82
  • [39] IMMUNOCYTOCHEMICAL AND ULTRASTRUCTURAL STUDY ON HEPATOCYTES IN ALPHA 1-ANTITRYPSIN DEFICIENCY
    FELDMANN, G
    BIGNON, J
    GUESNON, J
    GILET, M
    CHAHINIAN, P
    JOURNAL DE MICROSCOPIE, 1973, 17 (03): : A51 - A51
  • [40] Multiple, recurrent artery dissections in alpha 1-antitrypsin deficiency
    Leary, MC
    Kheradyar, D
    Schevon, CA
    Duckwiler, GR
    Saver, JL
    NEUROLOGY, 2002, 58 (07) : A478 - A478